Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases.
Daboussi F, Zaslavskiy M, Poirot L, Loperfido M, Gouble A, Guyot V, Leduc S, Galetto R, Grizot S, Oficjalska D, Perez C, Delacôte F, Dupuy A, Chion-Sotinel I, Le Clerre D, Lebuhotel C, Danos O, Lemaire F, Oussedik K, Cédrone F, Epinat JC, Smith J, Yáñez-Muñoz RJ, Dickson G, Popplewell L, Koo T, VandenDriessche T, Chuah MK, Duclert A, Duchateau P, Pâques F. Daboussi F, et al. Among authors: vandendriessche t. Nucleic Acids Res. 2012 Jul;40(13):6367-79. doi: 10.1093/nar/gks268. Epub 2012 Mar 29. Nucleic Acids Res. 2012. PMID: 22467209 Free PMC article.
Anti-viral strategies.
Chuah MK, VandenDriessche T, Morgan RA. Chuah MK, et al. Among authors: vandendriessche t. Mol Cell Biol Hum Dis Ser. 1995;5:175-94. doi: 10.1007/978-94-011-0547-7_10. Mol Cell Biol Hum Dis Ser. 1995. PMID: 9532567 Review. No abstract available.
Gene therapy for hemophilia: hopes and hurdles.
Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: vandendriessche t. Crit Rev Oncol Hematol. 1998 Sep;28(3):153-71. doi: 10.1016/s1040-8428(98)00022-5. Crit Rev Oncol Hematol. 1998. PMID: 9793744 Review. No abstract available.
Gene therapy for hemophilia.
Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: vandendriessche t. J Gene Med. 2001 Jan-Feb;3(1):3-20. doi: 10.1002/1521-2254(200101/02)3:1<3::AID-JGM167>3.0.CO;2-H. J Gene Med. 2001. PMID: 11269333 Review.
Viral vector-mediated gene therapy for hemophilia.
VandenDriessche T, Collen D, Chuah MK. VandenDriessche T, et al. Curr Gene Ther. 2001 Sep;1(3):301-15. doi: 10.2174/1566523013348508. Curr Gene Ther. 2001. PMID: 12109144 Review.
Biosafety of onco-retroviral vectors.
VandenDriessche T, Collen D, Chuah MK. VandenDriessche T, et al. Curr Gene Ther. 2003 Dec;3(6):501-15. doi: 10.2174/1566523034578113. Curr Gene Ther. 2003. PMID: 14683449
Biosafety of adenoviral vectors.
Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: vandendriessche t. Curr Gene Ther. 2003 Dec;3(6):527-43. doi: 10.2174/1566523034578140. Curr Gene Ther. 2003. PMID: 14683450
193 results